Squarepoint Ops LLC Adamis Pharmaceuticals Corp Transaction History

Squarepoint Ops LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.34 - $0.57 $206 - $345	-607 Reduced 5.18%	11,122 $6,000
Q1 2022 May 16, 2022	SELL	$0.55 - $0.73 $1,059 - $1,406	-1,927 Reduced 14.11%	11,729 $7,000
Q4 2021 Feb 14, 2022	BUY	$0.57 - $1.23 $246 - $531	432 Added 3.27%	13,656 $8,000
Q3 2021 Nov 15, 2021	SELL	$0.92 - $1.18 $92,886 - $119,137	-100,964 Reduced 88.42%	13,224 $13,000
Q2 2021 Aug 16, 2021	BUY	$0.66 - $1.23 $66,854 - $124,591	101,294 Added 785.59%	114,188 $126,000
Q1 2021 May 17, 2021	BUY	$0.54 - $1.79 $6,962 - $23,080	12,894 New	12,894 $12,000
Q4 2020 Feb 16, 2021	SELL	$0.4 - $1.01 $8,806 - $22,237	-22,017 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.52 - $1.45 $3,102 - $8,650	5,966 Added 37.17%	22,017 $17,000
Q2 2020 Aug 14, 2020	BUY	$0.33 - $0.66 $5,296 - $10,593	16,051 New	16,051 $9,000
Q4 2018 Feb 14, 2019	SELL	$2.1 - $3.21 $21,210 - $32,421	-10,100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.25 - $4.8 $22,725 - $48,480	10,100 New	10,100 $35,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.